Randomized controlled trial of acupuncture treatment of Irritable Bowel Syndrome

Research project of multi-acupoint co-effect and synergistic clinical program

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ITMCTR

Registry ID

ITMCTR2000004189

Enrollment

Unknown

Registered

2020-12-22

Start date

2021-01-01

Completion date

Unknown

Last updated

2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Irritable Bowel Syndrome

Interventions

Acupuncture group:acupuncture

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Subjects aged 18-70 years old; 2. Subjects with IBS according to Rome IV diagnostic criteria; 3. Patients with a course of at least 6 months; 4. Patients with IBS symptom severity score > 75 at baseline; 5. Patients with normal occult blood in stool in recent one month; 6. Subjects who voluntarily participated in this trial and signed informed consent. Note: all the above conditions were met before inclusion.

Exclusion criteria

Exclusion criteria: 1. Patients with intestinal organic lesions (including but not limited to ulcerative colitis and colorectal cancer) found by previous colonoscopy, barium meal fluoroscopy and abdominal ultrasound; 2. Patients with one or more of the following warning symptoms: hematochezia, fecal occult blood test positive, anemia, abdominal mass, ascites, fever, weight loss; 3. Patients with severe diseases of cardiovascular system, endocrine system and rheumatic immune system that affect the judgment of disease condition; 4. The patients with unconsciousness, inability to express subjective discomfort symptoms and severe mental disorder diagnosed clearly; 5. Patients with severe depression (SDS total score > 56); 6. Pregnant or lactating women; 7. Patients who have received acupuncture treatment for IBS in recent three months; Note: patients who meet any one of the above criteria are excluded.

Design outcomes

Primary

Measure	Time frame
IBS symptom severity scale;	—

Secondary

Measure	Time frame
Number of bowel movements per weekNumber of bowel movements per week;IBS Symptom Relief Assessment Form;Work and Social Adjustment Scale;the Bristol scale; the Irritable Bowel Syndrome-Quality of Life Measure (IBS-QOL scale);SAS, SDS;	—

Countries

China

Contacts

Public ContactZhigang Li

Beijing University of Chinese Medicine

lizhigang620@126.com+86 13693631588

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026